
|Videos|March 28, 2016
Guidelines Pharmacists Should Refer to When Selecting a Novel Oral Anticoagulant
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about what clinical guidelines pharmacists should refer to when selecting a novel oral anticoagulant.
Advertisement
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about what clinical guidelines pharmacists should refer to when selecting a novel oral anticoagulant.
This video was recorded at APhA's 2016 Annual Meeting and Exposition in Baltimore, Maryland.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists at the Forefront: Initiating, Monitoring, and Identifying Candidates for VMAT2 Therapy
2
Up to 5 Cups of Coffee Daily Safe—and Benficial—for Most Adults
3
Pharmacist Outreach Doubles SGLT2 Inhibitor Uptake in CKD
4
Understand the Patient Behind the Hesitation to Address Flu Vaccine Concerns
5





































































































